Insights · tech brief
AI Imaging Diagnostics in India: Tackling Brain, Lung, and Data Challenges
From brain tumor detection to COVID-19 lung scans, Indian innovators are building AI tools that overcome data scarcity and resource constraints to speed up accurate diagnoses.
Published 21 Jul 2026
- Market Momentum
- rising
- AI Adoption in Imaging
- accelerating
- India MedTech Growth
- double-digit trajectory
The problems being solved
Manual analysis of MRI and CT scans remains slow, subjective, and error-prone, delaying treatment for brain tumors. Radiologists must distinguish tumor types and boundaries, a task where fatigue and variability creep in. Innovators are targeting automated detection and classification that also surfaces interpretable reasoning, so clinicians can trust the output.
During the pandemic, overburdened diagnostic centers and slow RT-PCR results created an urgent need for fast, automated COVID-19 detection from chest X-rays and CT scans. The challenge was compounded by imbalanced datasets and the risk of false alarms, pushing work toward ensemble models that combine multiple imaging modalities.
Lung diseases—pneumonia, lung cancer, nodules—suffer from similar bottlenecks. Diagnosis often requires expert radiologists who are in short supply, especially outside major cities. Automated tools must work on edge devices with limited compute, integrate with electronic medical records, and preserve patient privacy when training across hospitals.
Underlying all this is a data problem: heterogeneous, non-IID datasets scattered across institutions, strict privacy requirements, and the need to train robust models without pooling sensitive images. Resource-constrained settings demand lightweight models that can run on portable or point-of-care devices.
How the field is solving it
Deep convolutional neural networks form the backbone, with architectures like DarkNet, YOLO, ResNet, and Inception-ResNet-v2 being adapted for specific diseases. Transfer learning from pre-trained models such as VGG16, ResNet50, and EfficientNetV2L helps overcome limited local datasets.
Ensemble and hybrid techniques are reducing false alarms by combining multiple classifiers—for instance, fusing CNN features with Random Committee or fuzzy logic with PCA. This is especially visible in COVID-19 detection, where stacking models trained on both CT and X-ray images lifts accuracy.
Privacy-preserving collaboration is emerging through federated learning, often paired with blockchain for audit trails. This allows hospitals to jointly train lung cancer or pneumonia detectors without moving patient data. Edge-optimized models are being designed to run inference directly on low-power devices, crucial for rural screening.
Vision Transformers are beginning to appear alongside traditional computer vision pipelines, tackling thoracic abnormality detection and multi-modal data fusion. Some systems integrate diagnostic output with provider selection and feedback loops, moving beyond pure classification toward clinical decision support.
Where the market is heading
Globally, the diagnostic imaging market sits at roughly USD 26–27 billion and is projected to reach over USD 32 billion by 2030, growing at a low-single-digit annual rate (MarketsandMarkets). The broader medical imaging equipment market is larger—around USD 44 billion in 2025, expected to climb to nearly USD 79 billion by 2034 (Fortune Business Insights). Asia Pacific already accounts for close to 40% of that market.
India’s MedTech sector, valued at USD 16–20 billion, is on a double-digit growth trajectory toward USD 24–30 billion by 2030 (PhotonDelta). The Ayushman Bharat Digital Mission is building a national digital health backbone, creating large-scale testbeds for AI-driven imaging and integration with electronic health records.
Several trends are shaping demand: AI and computer-aided diagnostics are becoming standard in TB screening programs (PFSCM); portable and mobile MRI solutions are expanding access to underserved areas; and supply chain disruptions are pushing hospitals to rethink capital equipment dependencies. Imaging’s role in infectious disease management, highlighted by COVID-19, is now extending to tuberculosis and other respiratory illnesses.
Price sensitivity remains a defining feature of the Indian market. Solutions that deliver high accuracy on affordable hardware, or that retrofit existing X-ray machines with AI, are likely to see faster adoption.
The white space
Federated learning on non-IID data is still maturing—there is room for frameworks that handle the extreme heterogeneity of Indian hospital datasets without sacrificing model performance. Pairing this with lightweight, explainable models for edge deployment opens a path to truly rural-first diagnostic AI.
Multi-modal integration remains underexplored. Combining imaging with pathology, genomics, or electronic health records could dramatically improve diagnostic precision, yet few systems attempt this in a privacy-compliant manner. Interpretability is another gap: clinicians need more than a black-box prediction; they need visual explanations and confidence scores they can act on.
Portable imaging hardware, such as mobile MRI or handheld ultrasound, is gaining traction globally. Indian innovators can couple these devices with AI that runs offline, syncing later with central registries. The ABDM infrastructure offers a ready-made platform for such connected diagnostics, but the tools to plug into it are still being built.
Beyond COVID-19, automated screening for tuberculosis, chronic obstructive pulmonary disease, and lung cancer represents a large, underserved need. Solutions that work with the low-dose CT scans and chest X-rays already available in district hospitals could have immediate public health impact.
Explore the innovators
The specific inventors, patents, and companies working on these challenges in India can be explored on Deeptech Navigator. Dive into the details of brain tumor segmentation models, federated learning frameworks for lung cancer, and edge AI for pneumonia detection—all emerging from India’s deep-tech ecosystem. The platform reveals who is building what, and where the novel technical approaches are being protected.
Knowledge graph
How the technologies, companies and players in this briefing connect.
problem
approach
technology
application
- Brain Tumor Detection uses MRI
- COVID-19 Diagnosis uses X-ray
- COVID-19 Diagnosis uses CT
- Pulmonary Disease Detection uses X-ray
- Pulmonary Disease Detection uses CT
- Data Privacy addressed_by Federated Learning
- Resource Constraints addressed_by Edge AI
- Convolutional Neural Networks applied_to Brain Tumor Detection
- Convolutional Neural Networks applied_to COVID-19 Diagnosis
- Convolutional Neural Networks applied_to Pulmonary Disease Detection
- Ensemble & Hybrid Methods improves COVID-19 Diagnosis
- Transfer Learning enables Pulmonary Disease Detection
- Vision Transformers applied_to Pulmonary Disease Detection
- Edge AI deployed_on Portable Imaging
- Federated Learning compatible_with ABDM Integration
In our data
Sectors
Technologies
Sources
- Modern Diagnostic Imaging Technique Applications and Risk ... ↗
- Diagnostic Imaging ↗
- How Medical Imaging and Scans Work ↗
- U.S. diagnostic imaging market faces tariff-driven supply chain ... ↗
- Eliminating Waste in the Medical Device Supply Chain | DAIC ↗
- Medical Imaging: Strengthening Healthcare Infrastructure ↗
- Diagnostic Imaging Market Report 2025-2030, By Modality, ... ↗
- Global Medical Imaging Market Size & Outlook, 2026-2033 ↗
This briefing is AI-generated from Deeptech Navigator's patent and startup data and lightly reviewed before publishing. Treat it as a starting point, not professional advice - figures are directional, so verify before relying on any number. The platform takes no responsibility for decisions made on it.
Related briefings
tech brief
India Makes the World's Medicines. It Buys the Molecules From China.
60 of 90 critical pharma ingredients India tracks run over 90% China-sourced. 6-APA, the penicillin core, runs 95.9%. Our largest deep-tech sector is funding AI diagnostics instead.
tech brief
India’s Oral Care Innovation: From Herbal Actives to Smart Brushing
Deep-tech analysis of India’s oral care landscape reveals a surge in natural formulations, targeted disease treatments, and device redesigns, driven by a market shifting toward wellness and sustainabi
tech brief
Surgical Instruments in India: Precision, Safety, and Smart Tools
India’s surgical innovators are tackling contamination, tissue trauma, and procedural inefficiency with smarter instruments—from single-use safety scalpels to sensor-guided staplers.
tech brief
Remote Patient Monitoring in India: Solving Access and Emergency Gaps
From AI-driven alerts to contactless sensors, Indian innovators are reshaping how chronic and rural care is delivered outside hospitals.
tech brief
India's Formulation Push: Solubility, Stability, Smarter Pills
From solubility enhancement to patient-friendly dosage forms, Indian formulation innovators are rethinking drug delivery.
Get in touch
Have a question on this - or want it researched for you?
Send a note: feedback on this briefing, a data question, or a scoped custom study on your specific market, geography or patent question. No account or card needed - we reply by email, usually within 1 business day.